Nanomedicine in treatment of breast cancer ? A challenge to conventional therapy

Amongst the various types of cancer, breast cancer is a highly heterogeneous disease and known as the leading cause of death among women globally. The extensive interdisciplinary investigation in nanotechnology and cancer biomedical research has been evolved over the years for its effective treatment. However, the advent of chemotherapeutic resistance in breast cancer is one of the major confront researchers are facing in achieving successful chemotherapy. Research in the area of cancer nanotechnology over the years have now been revolutionized through the development of smart polymers, lipids, inorganic materials and eventually their surface engineering with targeting ligands. Moreover, nanotechnology further extended and brings in the notice the new theranostic approach which combining the therapy and imaging simultaneously. Currently, research is being envisaged in the area of novel nano-pharmaceutical design viz. liposome, nanotubes, polymer lipid hybrid system, which focuses to make the chemotherapy curative and long-lasting. In this review, we aimed to discuss the recent advancement of different surface-engineered/targeted nanomedicines that improved the drug efficacy in breast cancer.

Automated summary

Breast cancer, a highly heterogeneous disease, is a leading cause of death among women globally. Chemotherapeutic resistance poses a major challenge in successful treatment. Nanotechnology research has revolutionized over the years, with the development of smart polymers, targeting ligands, and other advanced technologies. Novel nano-pharmaceutical design is focusing on making chemotherapy curative and long-lasting.